Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shing Y. Ma"'
Autor:
Wing Y. Au, Clarence C.K. Lam, Eric Tse, Yok L. Kwong, Shing Y. Ma, Anskar Y.H. Leung, Chor S. Chim, Albert K. W. Lie, Raymond Liang
Publikováno v:
British Journal of Haematology. 124:754-761
Summary The treatment results of indolent lymphoid malignancies in Chinese are poorly reported. The efficacy of FND (fludarabine 25 mg/m2/d, ×3; mitoxantrone 10 mg/m2/d, ×1; dexamethasone 20 mg/d, ×5; monthly cycles, ×6) in 95 Chinese patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::909867a96988c92ead78c7f999fc6d4e
https://doi.org/10.1111/j.1365-2141.2004.04852.x
https://doi.org/10.1111/j.1365-2141.2004.04852.x
Autor:
Raymond Liang, George K. K. Lau, Albert K. W. Lie, Irene Oi-Lin Ng, Shing Y. Ma, Anskar Y.H. Leung, Wing Y. Au, Yok L. Kwong
Publikováno v:
Transplantation. 77(8)
BACKGROUND Graft-versus-host disease (GVHD) of the liver after allogeneic hematopoietic stem cell transplantation classically presents with increased bilirubin and alkaline phosphatase (ALP) levels. A hepatitic variant was recently recognized, with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f10d002708115a8e78a88cd72eafd8e
https://pubmed.ncbi.nlm.nih.gov/15114094
https://pubmed.ncbi.nlm.nih.gov/15114094
Autor:
Shing Y, Ma, Wing Y, Au, Chor S, Chim, Albert K W, Lie, Clarence C K, Lam, Eric, Tse, Anskar Y H, Leung, Raymond, Liang, Yok L, Kwong
Publikováno v:
British journal of haematology. 124(6)
The treatment results of indolent lymphoid malignancies in Chinese are poorly reported. The efficacy of FND (fludarabine 25 mg/m2/d, x3; mitoxantrone 10 mg/m2/d, x1; dexamethasone 20 mg/d, x5; monthly cycles, x6) in 95 Chinese patients with indolent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04e81a2bfdad1c6c404ac79d0d77c6e4
https://pubmed.ncbi.nlm.nih.gov/15009063
https://pubmed.ncbi.nlm.nih.gov/15009063
Autor:
Cyrus R. Kumana, Shing Y. Ma, Raymond Liang, Eric Tse, Yok L. Kwong, Wing Y. Au, Albert K. W. Lie, Anskar Y.H. Leung, James Chim
Publikováno v:
Blood. 104:395-395
Background: The optimal therapy for relapsed acute promyelocytic leukemia (APL) after arsenic trioxide (As2O3)-induced remission is unclear. Hematopoietic stem cell transplantation (HSCT) is associated with high morbidity and mortality. Moreover, las
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8aec0a4c5e579fcef09152262fec495
https://doi.org/10.1182/blood.v104.11.395.395
https://doi.org/10.1182/blood.v104.11.395.395